1 INTRODUCTION Prostate cancer (PCa) is the most common cancer among men in Europe and second most common in the world.1-3 While advancements in diagnostic and therapeutic strategies have significantly improved survival rates, they have also introduced complex challenges in the management of low-risk PCa. Active surveillance (AS), a strategy involving regular monitoring of the cancer's progression without immediate intervention, has been established as a preferred approach for men with...